Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q
Authors
Keywords
-
Journal
PHARMACEUTICAL RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-24
DOI
10.1007/s11095-019-2747-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mode of PEG Coverage on Carbon Nanotubes Affects Binding of Innate Immune Protein C1q
- (2017) Agathe Belime et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Complement activation turnover on surfaces of nanoparticles
- (2017) S.M. Moghimi et al. Nano Today
- Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona
- (2016) Krishnendu Saha et al. ACS Nano
- An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
- (2016) Peter P. Wibroe et al. JOURNAL OF CONTROLLED RELEASE
- Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo
- (2016) Fangfang Chen et al. Nature Nanotechnology
- Emerging and Novel Functions of Complement Protein C1q
- (2015) Lubna Kouser et al. Frontiers in Immunology
- Cryptic Epitopes of Albumin Determine Mononuclear Phagocyte System Clearance of Nanomaterials
- (2014) Gysell M. Mortimer et al. ACS Nano
- Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
- (2014) Carl D. Walkey et al. ACS Nano
- Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles
- (2014) Yvonne Klapper et al. BIOMATERIALS
- C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression
- (2014) Gui-lian Xu et al. HEPATOLOGY
- Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth
- (2014) S.M. Moghimi JOURNAL OF CONTROLLED RELEASE
- Just so stories: The random acts of anti-cancer nanomedicine performance
- (2014) Seyed Moein Moghimi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Nanomedicine and the complement paradigm
- (2013) S. Moein Moghimi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
- (2013) Anna Salvati et al. Nature Nanotechnology
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
- (2013) Stefan Tenzer et al. Nature Nanotechnology
- Biomolecular coronas provide the biological identity of nanosized materials
- (2012) Marco P. Monopoli et al. Nature Nanotechnology
- Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis
- (2011) Stefan Tenzer et al. ACS Nano
- Advances in assay of complement function and activation
- (2011) Morten Harboe et al. ADVANCED DRUG DELIVERY REVIEWS
- Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
- (2011) S.M. Moghimi et al. Annual Review of Pharmacology and Toxicology
- Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
- (2011) Priya Prakash Karmali et al. Expert Opinion on Drug Delivery
- DNA affects the composition of lipoplex protein corona: A proteomics approach
- (2011) Anna L. Capriotti et al. PROTEOMICS
- Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
- (2011) A.I. Camacho et al. VACCINE
- Engineering complement activation on polypropylene sulfide vaccine nanoparticles
- (2010) Susan N. Thomas et al. BIOMATERIALS
- The non-classical functions of the classical complement pathway recognition subcomponent C1q
- (2010) Annapurna Nayak et al. IMMUNOLOGY LETTERS
- Complement Protein C1q Forms a Complex with Cytotoxic Prion Protein Oligomers
- (2010) Paul Erlich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces
- (2010) Christine T. N. Pham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation
- (2010) Martin Bjerregård Pedersen et al. JOURNAL OF IMMUNOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groups
- (2009) Carolina Salvador-Morales et al. BIOMATERIALS
- Immune Proteins in Brain Development and Synaptic Plasticity
- (2009) Lisa M. Boulanger NEURON
- Pathology, Molecular Biology, and Pathogenesis of Avian Influenza A (H5N1) Infection in Humans
- (2008) Christine Korteweg et al. AMERICAN JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started